Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2402-2405

  Raaijmakers, Renske ^a   Pluk, Wendy ^a   Schröder, Cornelis H ^b   Gloerich, Jolein ^a   Cornelissen, Elisabeth A M ^a   Wessels, Hans J C T ^a   Willems, Johannes L ^a   Monnens, Leo A H ^a   Van Den Heuvel, Lambert P W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Mass spectrometry; Paediatric; Peritoneal dialysis; Proteomics

Indexed keywords

PROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; DIALYSATE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PERITONEAL DIALYSIS; PERITONEAL FLUID; PERITONEUM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS;

ASCITIC FLUID; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; INFANT; MALE; PERITONEAL DIALYSIS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 46849109513     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn212     Document Type: Article

References (24)

1. Fliser D, Novak J, Thongboonkerd V et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 2007; 18: 1057-1071
2. Niwa T. Biomarker discovery for kidney diseases by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007;
3. Davis MT, Spahr CS, McGinley MD et al. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry: II. Limitations of complex mixture analyses. Proteomics 2001; 1: 108-117
4. Spahr CS, Davis MT, McGinley MD et al. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry: I. Profiling an unfractionated tryptic digest. Proteomics 2001; 1: 93-107
5. Sarto C, Marocchi A, Sanchez JC et al. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997; 18: 599-604
6. Miyamoto M, Yoshida Y, Taguchi I et al. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry. J Proteome Res 2007; 6: 3680-3690
7. Ransom RF, Vega-Warner V, Smoyer WE et al. Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int 2005; 67: 1275-1285
8. Weatherly DB, Astwood JA III, Minning TA et al. A heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol Cell Proteomics 2005; 4: 762-772
9. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29
10. Ishihama Y, Oda Y, Tabata T et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005; 4: 1265-1272
11. Yang Y, Thannhauser TW, Li L et al. Development of an integrated approach for evaluation of 2-D gel image analysis: impact of multiple proteins in single spots on comparative proteomics in conventional 2-D gel/MALDI workflow. Electrophoresis 2007; 28: 2080-2094
12. Au CE, Bell AW, Gilchrist A et al. Organellar proteomics to create the cell map. Curr Opin Cell Biol 2007; 19: 376-385
13. Pecoits-Filho R, Stenvinkel P, Wang AY et al. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004; 24: 327-339
14. Reddingius RE, Schroder CH, Daha MR et al. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 1995; 15: 49-53
15. Saku K, Sasaki J, Naito S et al. Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis. Nephron 1989; 51: 220-224
16. Van Der Kamp HJ, Otten BJ, Swinkels LM et al. Influence of peritoneal loss of GHBP, IGF-I and IGFBP-3 on serum levels in children with ESRD. Nephrol Dial Transplant 1999; 14: 257-258
17. Sritippayawan S, Chiangjong W, Semangoen T et al. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes. J Proteome Res 2007; 6: 4356-4362
18. Dinubile MJ. Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin". Am J Physiol Cell Physiol 2007; 292: C1240-C1242
19. Lee PS, Waxman AB, Cotich KL et al. Plasma gelsolin is amarker and therapeutic agent in animal sepsis. Crit Care Med 2007; 35: 849-855
20. Schaffler A, Neumeier M, Herfarth H et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102
21. Datta R, deSchoolmeester ML et al. Identification of novel genes in intestinal tissue that are regulated after infection with an intestinal nematode parasite. Infect Immun 2005; 73: 4025-4033
22. Mackness MI, Mackness B, Durrington PN et al. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69-76
23. Dantoine TF, Debord J, Charmes JP et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998; 9: 2082-2088
24. Ece A, Atamer Y, Gurkan F et al. Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol 2006; 21: 239-245